Reversibilitets- data tilgængelige hos 35, 3% af de patienter, som udviklede neurotoksicitet efter docetaxel- behandling med 100 mg/ m2 som enkelt stof.
Nervous system disorders Reversibility data are available among 35.3% of patients who developed neurotoxicity following docetaxel treatment at 100 mg/ m² as single agent.